CN111544354A - 一种皮肤抑菌私处护理液及其制备方法 - Google Patents
一种皮肤抑菌私处护理液及其制备方法 Download PDFInfo
- Publication number
- CN111544354A CN111544354A CN202010452363.4A CN202010452363A CN111544354A CN 111544354 A CN111544354 A CN 111544354A CN 202010452363 A CN202010452363 A CN 202010452363A CN 111544354 A CN111544354 A CN 111544354A
- Authority
- CN
- China
- Prior art keywords
- parts
- care solution
- bacteriostatic
- chlorhexidine acetate
- menthol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003385 bacteriostatic effect Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 54
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229960002152 chlorhexidine acetate Drugs 0.000 claims abstract description 27
- -1 polyhexamethylene guanidine Polymers 0.000 claims abstract description 22
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 19
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 19
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960000458 allantoin Drugs 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 229940041616 menthol Drugs 0.000 claims abstract description 19
- 239000008213 purified water Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 240000003538 Chamaemelum nobile Species 0.000 claims abstract description 17
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 17
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 17
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Abstract
本发明提供一种皮肤抑菌私处护理液,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.01‑0.1份、醋酸氯己定0.05‑0.5份、薄荷醇0.01‑0.5份、椰油基甘油酯0.02‑0.5份、胶原蛋白0.01‑0.1份、尿囊素0.1‑0.5份、洋甘菊0.1‑0.5份、甘油2.0‑8.0份、乙醇1.0‑75份、纯化水25‑98份。本发明提供一种稳定性高、储存方便的、抑菌效果好的皮肤抑菌私处护理液及其制备方法。
Description
技术领域
本发明涉及卫生保健及医药保健外用液剂,特别涉及一种皮肤抑菌私处护理液及其制备方法。
背景技术
目前,市场上很多种适用于男女性私处用的抑菌护理液,它们一般都具有清洁男女性私处、防治细菌感染等功效。然而,这些护理液中大多主要抗菌成分是醋酸氯己定,醋酸氯已定具有抗菌谱广、抗菌作用较强的特点,对革兰阳性菌及革兰阴性菌均有效,但是现有的护理液中醋酸氯己定中的稳定性不高,大多数情况适宜在低温的状态下进行储存,并且醋酸氯己定遇阴离子表面活性剂易发生反应失去抗菌活性。
因此,需要设计一种稳定性高、储存方便的、抑菌效果好的皮肤抑菌私处护理液及其制备方法。
发明内容
本发明的目的在于提供一种稳定性高、储存方便的、抑菌效果好的皮肤抑菌私处护理液及其制备方法。
本发明的上述技术目的是通过以下技术方案得以实现的:
一种皮肤抑菌私处护理液,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.01-0.1份、醋酸氯己定0.05-0.5份、薄荷醇0.01-0.5份、椰油基甘油酯0.02-0.5份、胶原蛋白0.01-0.1份、尿囊素0.1-0.5份、洋甘菊0.1-0.5份、甘油2.0-8.0份、乙醇1.0-75份、纯化水25-98份。
作为本发明的进一步设置,还包括香精1-10份。
作为本发明的进一步设置,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.05份、醋酸氯己定0.2份、薄荷醇0.2份、椰油基甘油酯0.2份、胶原蛋白0.5份、尿囊素0.2份、洋甘菊0.2份、甘油6.0份、乙醇50份、纯化水50份、香精5份。
还提供一种皮肤抑菌私处护理液的制备方法,包括以下步骤:
步骤S1:称取醋酸氯己定、尿囊素、洋甘菊、薄荷醇、胶原蛋白,精密称定,备用;
步骤S2:量取甘油、乙醇、椰油基甘油酯、聚六亚甲基胍、香精,备用;
步骤S3:取纯净水适量,加入尿囊素、洋甘菊、胶原蛋白、甘油,搅拌溶解至完全,备用;
步骤S4:用乙醇溶解醋酸氯己定、薄荷醇,依次加入香精、椰油基甘油酯、聚六亚甲基胍,搅拌均匀,备用;
步骤S5:合并所有备用物料,搅拌均匀;
步骤S6:加纯净水至需要量,过滤,分装。
本发明的有益效果是:
1.本发明中采用聚六亚甲基胍与醋酸氯己定形成复合配方,其相互之间互相作用,协同增效,提高皮肤私处护理液的抑菌杀菌能力,并且聚六亚甲基胍的胍基能与醋酸氯己定相作用,提高醋酸氯己定的耐温度变化的能力,而且提高了醋酸氯己定的表面活性剂的耐受能力,有效提高本护理液的储存稳定性。
2.本发明的在聚六亚甲基胍与醋酸氯己定的基础上,还复配有薄荷醇、洋甘菊,能对私处进行清凉、消炎、舒缓炎症影响,提高本护理液对私处的护理保健作用。
3.本发明还添加有椰油基甘油酯、胶原蛋白和尿囊素,能使得本皮肤护理液在抑菌的效果之上能对私处的皮肤进行护理、保湿,并且有效修复炎症对私处皮肤的破坏,同时降低醋酸氯己定对私处菌群结构的影响及对皮肤细胞的损害作用,有效保护私处的菌群平衡、及时修复受损皮肤细胞,改善私处皮肤状态。
具体实施方式
下面将结合具体实施例对本发明的技术方案进行清楚、完整地描述。显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
一、实施例
实施例1
一种皮肤抑菌私处护理液,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.01-0.1份、醋酸氯己定0.05份、薄荷醇0.01份、椰油基甘油酯0.02份、胶原蛋白0.01份、尿囊素0.1份、洋甘菊0.1份、甘油2.0份、乙醇1.0份、纯化水25份、香精1份。
还提供一种皮肤抑菌私处护理液的制备方法,包括以下步骤:
步骤S1:称取0.05份醋酸氯己定、0.1份尿囊素、0.1份洋甘菊、0.01份薄荷醇、0.01份胶原蛋白,精密称定,备用;
步骤S2:量取2.0份甘油、1.0份乙醇、0.02份椰油基甘油酯、0.01份聚六亚甲基胍、1-10份香精,备用;
步骤S3:取纯净水适量,加入尿囊素、洋甘菊、胶原蛋白、甘油,搅拌溶解至完全,备用;
步骤S4:用乙醇溶解醋酸氯己定、薄荷醇,依次加入香精、椰油基甘油酯、聚六亚甲基胍,搅拌均匀,备用;
步骤S5:合并所有备用物料,搅拌均匀;
步骤S6:加纯净水至需要量,过滤,分装。
实施例2
一种皮肤抑菌私处护理液,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.1份、醋酸氯己定0.5份、薄荷醇0.5份、椰油基甘油酯0.5份、胶原蛋白0.1份、尿囊素0.5份、洋甘菊0.5份、甘油8.0份、乙醇75份、纯化水98份、香精10份。
还提供一种皮肤抑菌私处护理液的制备方法,包括以下步骤:
步骤S1:称取0.5份醋酸氯己定、0.5份尿囊素、0.5份洋甘菊、0.5份薄荷醇、0.1份胶原蛋白,精密称定,备用;
步骤S2:量取8.0份甘油、75份乙醇、0.5份椰油基甘油酯、0.1份聚六亚甲基胍、10份香精,备用;
步骤S3:取纯净水适量,加入尿囊素、洋甘菊、胶原蛋白、甘油,搅拌溶解至完全,备用;
步骤S4:用乙醇溶解醋酸氯己定、薄荷醇,依次加入香精、椰油基甘油酯、聚六亚甲基胍,搅拌均匀,备用;
步骤S5:合并所有备用物料,搅拌均匀;
步骤S6:加纯净水至需要量,过滤,分装。
实施例3
一种皮肤抑菌私处护理液,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.05份、醋酸氯己定0.2份、薄荷醇0.2份、椰油基甘油酯0.2份、胶原蛋白0.5份、尿囊素0.2份、洋甘菊0.2份、甘油6.0份、乙醇50份、纯化水50份、香精5份。
还提供一种皮肤抑菌私处护理液的制备方法,包括以下步骤:
步骤S1:称取0.2份醋酸氯己定、0.2份尿囊素、0.2份洋甘菊、0.2份薄荷醇、0.5份胶原蛋白,精密称定,备用;
步骤S2:量取6.0份甘油、50份乙醇、0.2份椰油基甘油酯、0.05份聚六亚甲基胍、5份香精,备用;
步骤S3:取纯净水适量,加入尿囊素、洋甘菊、胶原蛋白、甘油,搅拌溶解至完全,备用;
步骤S4:用乙醇溶解醋酸氯己定、薄荷醇,依次加入香精、椰油基甘油酯、聚六亚甲基胍,搅拌均匀,备用;
步骤S5:合并所有备用物料,搅拌均匀;
步骤S6:加纯净水至需要量,过滤,分装。
Claims (4)
1.一种皮肤抑菌私处护理液,其特征在于,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.01-0.1份、醋酸氯己定0.05-0.5份、薄荷醇0.01-0.5份、椰油基甘油酯0.02-0.5份、胶原蛋白0.01-0.1份、尿囊素0.1-0.5份、洋甘菊0.1-0.5份、甘油2.0-8.0份、乙醇1.0-75份、纯化水25-98份。
2.根据权利要求1所述的皮肤抑菌私处护理液,其特征在于,还包括香精1-10份。
3.根据权利要求2所述的皮肤抑菌私处护理液,其特征在于,按重量份数计,由以下原料制备而成:聚六亚甲基胍0.05份、醋酸氯己定0.2份、薄荷醇0.2份、椰油基甘油酯0.2份、胶原蛋白0.5份、尿囊素0.2份、洋甘菊0.2份、甘油6.0份、乙醇50份、纯化水50份、香精5份。
4.一种根据权利要求1-3任一所述的皮肤抑菌私处护理液的制备方法,其特征在于,包括以下步骤:
步骤S1:称取醋酸氯己定、尿囊素、洋甘菊、薄荷醇、胶原蛋白,精密称定,备用;
步骤S2:量取甘油、乙醇、椰油基甘油酯、聚六亚甲基胍、香精,备用;
步骤S3:取纯净水适量,加入尿囊素、洋甘菊、胶原蛋白、甘油,搅拌溶解至完全,备用;
步骤S4:用乙醇溶解醋酸氯己定、薄荷醇,依次加入香精、椰油基甘油酯、聚六亚甲基胍,搅拌均匀,备用;
步骤S5:合并所有备用物料,搅拌均匀;
步骤S6:加纯净水至需要量,过滤,分装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010452363.4A CN111544354A (zh) | 2020-05-26 | 2020-05-26 | 一种皮肤抑菌私处护理液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010452363.4A CN111544354A (zh) | 2020-05-26 | 2020-05-26 | 一种皮肤抑菌私处护理液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111544354A true CN111544354A (zh) | 2020-08-18 |
Family
ID=71997035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010452363.4A Pending CN111544354A (zh) | 2020-05-26 | 2020-05-26 | 一种皮肤抑菌私处护理液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111544354A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518658A (zh) * | 2009-04-01 | 2009-09-02 | 天津美真泰克化工有限公司 | 用于卫生巾的泡腾制剂组合物和制备方法及应用 |
CN101905041A (zh) * | 2009-06-08 | 2010-12-08 | 上海市计划生育科学研究所 | 阴道酸性润滑剂及其制备方法和用途 |
CN101991519A (zh) * | 2010-11-01 | 2011-03-30 | 江西中兴汉方药业有限公司 | 抑菌洗液及其制备方法 |
CN103705535A (zh) * | 2013-12-27 | 2014-04-09 | 王东宇 | 壳聚糖妇科凝胶及其制备方法 |
CN104857499A (zh) * | 2015-05-15 | 2015-08-26 | 张计划 | 一种洁阴护理洗液及其制备方法 |
CN105055183A (zh) * | 2015-08-03 | 2015-11-18 | 李彦 | 一种用于女性阴道的清洁护理液及其制备方法 |
US20180333375A1 (en) * | 2017-05-17 | 2018-11-22 | Beijing Textile Medical Technology & Development Co.,Ltd. | Compound for treating open injury, and preparation method and application thereof |
-
2020
- 2020-05-26 CN CN202010452363.4A patent/CN111544354A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101518658A (zh) * | 2009-04-01 | 2009-09-02 | 天津美真泰克化工有限公司 | 用于卫生巾的泡腾制剂组合物和制备方法及应用 |
CN101905041A (zh) * | 2009-06-08 | 2010-12-08 | 上海市计划生育科学研究所 | 阴道酸性润滑剂及其制备方法和用途 |
CN101991519A (zh) * | 2010-11-01 | 2011-03-30 | 江西中兴汉方药业有限公司 | 抑菌洗液及其制备方法 |
CN103705535A (zh) * | 2013-12-27 | 2014-04-09 | 王东宇 | 壳聚糖妇科凝胶及其制备方法 |
CN104857499A (zh) * | 2015-05-15 | 2015-08-26 | 张计划 | 一种洁阴护理洗液及其制备方法 |
CN105055183A (zh) * | 2015-08-03 | 2015-11-18 | 李彦 | 一种用于女性阴道的清洁护理液及其制备方法 |
US20180333375A1 (en) * | 2017-05-17 | 2018-11-22 | Beijing Textile Medical Technology & Development Co.,Ltd. | Compound for treating open injury, and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
崔玉杰,等: "聚六亚甲基双肌与醋酸氯己定协同作用研究", 《医学动物防制》 * |
王建红,等: "妇科洗液抑菌效果观察", 《中国消毒学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009254255B2 (en) | Synergistic preservative blends | |
CN101543467A (zh) | 一种芦荟凝胶及其制备方法 | |
CN103330659B (zh) | 一种防蚊湿巾制作用药液 | |
JP2013526559A5 (zh) | ||
CN111544354A (zh) | 一种皮肤抑菌私处护理液及其制备方法 | |
RU2013102294A (ru) | Бактерицидные топические композиции | |
CN105106292A (zh) | 多糖生物医用胶体液及制备方法 | |
WO2011096688A3 (ko) | 디벤조-р-디옥신 유도체를 포함하는 두피 및 모발 건강 개선용 조성물 | |
CN101129409B (zh) | 一种抗真菌类外用药 | |
CN112168729A (zh) | 一种迷迭香消毒洗手液及其制备方法 | |
Calow et al. | Contact dermatitis due to use of Octenisept® in wound care | |
KR102154052B1 (ko) | 플로로탄닌을 유효성분으로 포함하는 피부 냉각용 조성물 및 제품 | |
CN111686070A (zh) | 一种添加水溶性cbd油溶性cbd凝胶 | |
CN112315840A (zh) | 一种贻贝粘蛋白头皮修护组合物、修护液及其制备方法 | |
CN114259424A (zh) | 一种含桃柁酚与伞花烃的无水抑菌牙膏及其制作方法 | |
CN105288708A (zh) | 用于敷料的抗菌溶液、抗菌敷料及抗菌敷料的制备方法 | |
CN113476318A (zh) | 一种有机云母抑菌组合物、口腔清洁护理产品及其制备方法和应用 | |
CN110731932A (zh) | 一种植物抑菌乳膏及其制备方法 | |
CN112156056A (zh) | 一种植物防蚊喷雾其制备方法 | |
KR101326679B1 (ko) | 폴리글리세릴-2 디폴리하이드록시스테아레이트로안정화시킨 산화 아연을 포함하는 기저귀 발진 완화용 또는치료용 외용제 조성물 | |
CN110604705A (zh) | 一种婴儿山茶油护臀膏的配方及制备方法 | |
EP3988079A1 (en) | Preservative for externally-applied dermal preparation, and cosmetic composition and pharmaceutical composition each comprising same | |
CN104306233A (zh) | 一种芦荟抑菌洗手液 | |
CN112168759A (zh) | 一种婴幼儿润肤乳及其制备方法 | |
JP2017114823A (ja) | 濃縮抗菌剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220429 Address after: No.26 jiaolongqiao Road, high tech Zone, Chibi City, Xianning City, Hubei Province 437300 Applicant after: Hubei sibelin Biotechnology Co.,Ltd. Address before: 437300 intersection of Guanggu Zongyi road and Guanggu henger Road, Chibi Avenue, Chibi City, Xianning City, Hubei Province Applicant before: Hubei Huihai Pharmaceutical Research Institute (L.P.) |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200818 |